NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » whitepapers » Advance of sepsis testing

Bruker Daltonics GmbH & Co. KG - Bruker Microbiology & Infection Diagnostics – Changing Microbiology

White Paper

Advance of sepsis testing

Sepsis is a global killer, and its mortality rate requires special testing so treatment can be tailored to the microorganisms causing infection. Ike Northern, director of infectious disease testing and immunology at CompuNet Clinical Laboratories, explains how his company has used Bruker’s matrix-assisted laser desorption/ionisation time-of-flight mass spectrometer with the aim to optimise patient treatment.

Download to find out more.

Download White Paper